GWM
GILD icon

Gibbs Wealth Management’s Gilead Sciences GILD Stock Holding History

Gibbs Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$924K Buy
6,629
+2,421
+58% +$339K 0.12% 168
2025
Q4 		$510K Sell
4,208
-466
-10% -$56.6K 0.12% 199
2025
Q3 		$519K Sell
4,674
-724
-13% -$82.3K 0.12% 207
2025
Q2 		$598K Buy
5,398
+957
+22% +$102K 0.12% 203
2025
Q1 		$498K Buy
4,441
+490
+12% +$50.6K 0.12% 189
2024
Q4 		$365K Buy
3,951
+162
+4% +$14.6K 0.1% 209
2024
Q3 		$318K Buy
+3,789
New +$289K 0.1% 207

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Gibbs Wealth Management's GILD Position: Q1 2026 in Review

Gibbs Wealth Management increased its Gilead Sciences (GILD) stake by 58% in Q1 2026, buying an estimated $339K and bringing the position to 6,629 shares worth $924K. The position accounts for 0.12% of the portfolio, ranked #168.

Gibbs Wealth Management first reported a position in GILD in Q3 2024 and has held it in 7 quarters since. 2,331 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Gibbs Wealth Management held 6,629 shares of Gilead Sciences worth $924K as of Q1 2026.
  • Gibbs Wealth Management bought 2,421 Gilead Sciences shares in Q1 2026, an estimated $339K.
  • Gilead Sciences made up 0.12% of Gibbs Wealth Management's portfolio in Q1 2026, its #168 holding.
  • Gibbs Wealth Management first reported a position in Gilead Sciences in Q3 2024 and has held it in 7 quarters since.
  • 2,331 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Gibbs Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.